Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1992 1
1993 1
1994 2
1995 1
1997 1
1998 5
1999 2
2000 3
2001 3
2002 4
2003 9
2004 6
2005 5
2006 5
2007 7
2008 11
2009 8
2010 2
2011 1
2012 3
2013 4
2014 3
2015 4
2016 6
2017 6
2018 2
2019 1
2020 3
2021 2
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Results by year

Filters applied: . Clear all
Page 1
The biology of VEGF and its receptors.
Ferrara N, Gerber HP, LeCouter J. Ferrara N, et al. Among authors: gerber hp. Nat Med. 2003 Jun;9(6):669-76. doi: 10.1038/nm0603-669. Nat Med. 2003. PMID: 12778165 Review.
A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions.
Damelin M, Bankovich A, Bernstein J, Lucas J, Chen L, Williams S, Park A, Aguilar J, Ernstoff E, Charati M, Dushin R, Aujay M, Lee C, Ramoth H, Milton M, Hampl J, Lazetic S, Pulito V, Rosfjord E, Sun Y, King L, Barletta F, Betts A, Guffroy M, Falahatpisheh H, O'Donnell CJ, Stull R, Pysz M, Escarpe P, Liu D, Foord O, Gerber HP, Sapra P, Dylla SJ. Damelin M, et al. Among authors: gerber hp. Sci Transl Med. 2017 Jan 11;9(372):eaag2611. doi: 10.1126/scitranslmed.aag2611. Sci Transl Med. 2017. PMID: 28077676
Identification of Antigenic Targets.
Gerber HP, Sibener LV, Lee LJ, Gee MH. Gerber HP, et al. Trends Cancer. 2020 Apr;6(4):299-318. doi: 10.1016/j.trecan.2020.01.002. Epub 2020 Feb 20. Trends Cancer. 2020. PMID: 32209445 Review.
Next-Generation Antibody-Drug Conjugates (ADCs) for Cancer Therapy.
Junutula JR, Gerber HP. Junutula JR, et al. Among authors: gerber hp. ACS Med Chem Lett. 2016 Nov 10;7(11):972-973. doi: 10.1021/acsmedchemlett.6b00421. eCollection 2016 Nov 10. ACS Med Chem Lett. 2016. PMID: 27882192 Free PMC article. No abstract available.
Mechanisms of Resistance to Antibody-Drug Conjugates.
Loganzo F, Sung M, Gerber HP. Loganzo F, et al. Among authors: gerber hp. Mol Cancer Ther. 2016 Dec;15(12):2825-2834. doi: 10.1158/1535-7163.MCT-16-0408. Epub 2016 Oct 25. Mol Cancer Ther. 2016. PMID: 27780876 Review.
Angiogenesis and bone growth.
Gerber HP, Ferrara N. Gerber HP, et al. Trends Cardiovasc Med. 2000 Jul;10(5):223-8. doi: 10.1016/s1050-1738(00)00074-8. Trends Cardiovasc Med. 2000. PMID: 11282299 Review.
Investigational antibody drug conjugates for solid tumors.
Sapra P, Hooper AT, O'Donnell CJ, Gerber HP. Sapra P, et al. Among authors: gerber hp. Expert Opin Investig Drugs. 2011 Aug;20(8):1131-49. doi: 10.1517/13543784.2011.582866. Epub 2011 May 23. Expert Opin Investig Drugs. 2011. PMID: 21599617 Review.
102 results